Yim, H.J.; Kang, S.H.; Jung, Y.K.; Ahn, S.H.; Kim, W.; Yang, J.M.; Jang, J.Y.; Kweon, Y.O.; Cho, Y.K.; Kim, Y.J.;
et al. Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy. Cancers 2024, 16, 887.
https://doi.org/10.3390/cancers16050887
AMA Style
Yim HJ, Kang SH, Jung YK, Ahn SH, Kim W, Yang JM, Jang JY, Kweon YO, Cho YK, Kim YJ,
et al. Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy. Cancers. 2024; 16(5):887.
https://doi.org/10.3390/cancers16050887
Chicago/Turabian Style
Yim, Hyung Joon, Seong Hee Kang, Young Kul Jung, Sang Hoon Ahn, Won Kim, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim,
and et al. 2024. "Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy" Cancers 16, no. 5: 887.
https://doi.org/10.3390/cancers16050887
APA Style
Yim, H. J., Kang, S. H., Jung, Y. K., Ahn, S. H., Kim, W., Yang, J. M., Jang, J. Y., Kweon, Y. O., Cho, Y. K., Kim, Y. J., Hong, G. Y., Kim, D. J., Sohn, J. H., Lee, J. W., Park, S. J., Yim, S. Y., Park, J. K., & Um, S. H.
(2024). Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy. Cancers, 16(5), 887.
https://doi.org/10.3390/cancers16050887
